GlassScriptPhysician profile
David F Davis
NPI 1144245549
$8,475.85
in general payments reported to CMS, 2019-2025
28 companies · $3,703 in 2025
The $3,703 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $401 · 2021: $651 · 2022: $610 · 2023: $2,619 · 2024: $342 · 2025: $3,703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,133 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,900 · Food and Beverage: $1,349 · Travel and Lodging: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,132.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,900.00 |
| Food and Beverage | $1,348.77 |
| Travel and Lodging | $1,283.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $3,183.10 | 2025 | Prospera |
| Cashflow Solutions, LLC | $2,132.50 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Pfizer INC. | $622.97 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $437.96 | 2019-2025 | |
| Abbott Laboratories | $275.25 | 2020-2025 | Assurity, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Heartflow, INC. | $266.74 | 2020-2022 | |
| Amgen INC. | $198.71 | 2019-2025 | Repatha |
| Cvrx, INC. | $131.23 | 2024-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $124.49 | 2020-2022 | |
| Abbvie INC. | $123.68 | 2023 | Vraylar |
| Boston Scientific Corporation | $115.92 | 2022-2025 | Varithena Administration Pack, Watchman Flx |
| Merck Sharp & Dohme LLC | $112.30 | 2021-2025 | Verquvo |
| Atricure, INC. | $108.00 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $104.51 | 2022-2025 | Camzyos, Eliquis |
| Cleerly, INC. | $95.32 | 2025 | Cleerly Ischemia, Cleerly Labs |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $91.33 | 2021-2024 | Rybelsus, Ozempic |
| Esperion Therapeutics, INC. | $80.75 | 2020-2021 | |
| Impulse Dynamics (USA) INC. | $65.26 | 2022-2023 | Optimizer |
| Abiomed | $37.81 | 2025 | |
| Silk Road Medical, INC. | $23.62 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Edwards Lifesciences Corporation | $22.09 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.49 | 2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $20.61 | 2021 | |
| Astellas Pharma US INC | $20.41 | 2020 | |
| Baxter Healthcare | $17.74 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Medicomp INC | $14.95 | 2022 | |
| Amarin Pharma, INC. | $14.50 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $12.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.